Creative Medical Technology (CELZ) Expected to Announce Earnings on Friday

Creative Medical Technology (NASDAQ:CELZ) is expected to be posting its quarterly earnings results before the market opens on Friday, March 28th. Analysts expect Creative Medical Technology to post earnings of ($0.63) per share for the quarter.

Creative Medical Technology Stock Performance

CELZ stock opened at $2.20 on Wednesday. The business’s 50-day moving average is $3.77 and its two-hundred day moving average is $3.25. Creative Medical Technology has a fifty-two week low of $1.96 and a fifty-two week high of $6.90. The company has a market cap of $3.85 million, a price-to-earnings ratio of -0.58 and a beta of 1.70.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.